Evidence map›Paper›PMID 41492391›Full record

ArticleiScience2025

TET3 protects the

Laura Lázaro-Carot, Esteban Jiménez-Villalba, Jordi Planells, Anna Lozano-Ureña, Jennifer Díaz-Moncho, Raquel Montalbán-Loro, Adela Lleches-Padilla, Martina Kirstein, Mitsuteru Ito, Elizabeth J Radford and 1 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura Lázaro-CarotInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Esteban Jiménez-VillalbaInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Jordi PlanellsInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Anna Lozano-UreñaInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Jennifer Díaz-MonchoInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Raquel Montalbán-LoroInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Adela Lleches-PadillaInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Martina KirsteinInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.
Mitsuteru ItoDepartment of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
Elizabeth J RadfordDepartment of Pediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
Sacri R FerrónInstituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, 46100 Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic imprinting is an epigenetic mechanism that controls monoallelic expression according to parental origin. Imprinted genes are regulated by DNA methylation at imprinting control regions (ICRs), differentially methylated regions (DMRs) that distinguish between parental alleles. Cell reprogramming into induced pluripotent stem cells (iPSCs) offers a valuable model for studying pluripotency. Thus, discerning whether genomic imprinting changes during reprogramming represent epigenetic abnormalities or essential adaptations of pluripotency is crucial. Here, we integrate RNA-seq and MeDIP-seq analysis to profile mouse iPSCs derived from adult neural stem cells (NSCs). Our findings reveal that most ICRs undergo DNA hypomethylation in iPSCs, although the IG-DMR within the

Indexed as

EpigeneticsGenomicsMolecular GeneticsStem cells researchTranscriptomics

Identifiers

PMID41492391
PMCPMC12765442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.